Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 5
2015 1
2016 1
2017 1
2018 3
2019 2
2020 1
2021 6
2022 6
2023 30
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.
Bao S, Darvishi M, H Amin A, Al-Haideri MT, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-Qaim ZH, Al-Gazally ME, Kiasari BA, Tavakoli-Far B, Sidikov AA, Mustafa YF, Akhavan-Sigari R. Bao S, et al. Among authors: akhavan sigari r. J Cancer Res Clin Oncol. 2023 Aug;149(10):7945-7968. doi: 10.1007/s00432-022-04444-w. Epub 2023 Mar 11. J Cancer Res Clin Oncol. 2023. PMID: 36905421 Review.
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, Saadh MJ, Amajd A, Abo-Zaid MA, Castillo-Acobo RY, Ismail AH, Amin AH, Akhavan-Sigari R. Chehelgerdi M, et al. Among authors: akhavan sigari r. Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0. Mol Cancer. 2023. PMID: 37814270 Free PMC article. Review.
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date.
Nikoo M, Rabiee F, Mohebbi H, Eghbalifard N, Rajabi H, Yazdani Y, Sakhaei D, Khosravifarsani M, Akhavan-Sigari R. Nikoo M, et al. Among authors: akhavan sigari r. Int Immunopharmacol. 2023 Apr;117:109881. doi: 10.1016/j.intimp.2023.109881. Epub 2023 Mar 2. Int Immunopharmacol. 2023. PMID: 37012882 Review.
Recent advances in non-small cell lung cancer targeted therapy; an update review.
Araghi M, Mannani R, Heidarnejad Maleki A, Hamidi A, Rostami S, Safa SH, Faramarzi F, Khorasani S, Alimohammadi M, Tahmasebi S, Akhavan-Sigari R. Araghi M, et al. Among authors: akhavan sigari r. Cancer Cell Int. 2023 Aug 11;23(1):162. doi: 10.1186/s12935-023-02990-y. Cancer Cell Int. 2023. PMID: 37568193 Free PMC article. Review.
Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19.
Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Shafiee S, et al. Among authors: akhavan sigari r. Cancer Cell Int. 2021 Aug 16;21(1):431. doi: 10.1186/s12935-021-02129-x. Cancer Cell Int. 2021. PMID: 34399734 Free PMC article. Review.
Oncogenic miRNAs and target therapies in colorectal cancer.
Saberinia A, Alinezhad A, Jafari F, Soltany S, Akhavan Sigari R. Saberinia A, et al. Among authors: akhavan sigari r. Clin Chim Acta. 2020 Sep;508:77-91. doi: 10.1016/j.cca.2020.05.012. Epub 2020 May 11. Clin Chim Acta. 2020. PMID: 32407782 Review.
Oncolytic viruses: A novel treatment strategy for breast cancer.
Javanbakht M, Tahmasebzadeh S, Cegolon L, Gholami N, Kashaki M, Nikoueinejad H, Mozafari M, Mozaffari M, Zhao S, Khafaei M, Izadi M, Fathi S, Akhavan-Sigari R. Javanbakht M, et al. Among authors: akhavan sigari r. Genes Dis. 2021 Dec 16;10(2):430-446. doi: 10.1016/j.gendis.2021.11.011. eCollection 2023 Mar. Genes Dis. 2021. PMID: 37223527 Free PMC article. Review.
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
Ghasemi Darestani N, Gilmanova AI, Al-Gazally ME, Zekiy AO, Ansari MJ, Zabibah RS, Jawad MA, Al-Shalah SAJ, Rizaev JA, Alnassar YS, Mohammed NM, Mustafa YF, Darvishi M, Akhavan-Sigari R. Ghasemi Darestani N, et al. Among authors: akhavan sigari r. Cell Commun Signal. 2023 Feb 24;21(1):43. doi: 10.1186/s12964-022-01012-0. Cell Commun Signal. 2023. PMID: 36829187 Free PMC article. Review.
60 results